“COST ANALYSIS OF PATIENTS WITH SQUAMOUS CELL CERVICAL CANCER STAGE IIB-IIIB WITH PACLITAXEL CISPLATIN CHEMOTHERAPY FROM THE SOCIETAL PERSPECTIVE” (2023) Journal Pharmaceutical Science and Application, 5(1), pp. 34–44. doi:10.24843/JPSA.2023.v05.i01.p05.